Author:
Paradiso Angelo,Pezzetta A.,Cellamare G.,Schittulli F.,Marzullo F.,Reshkin S. J.
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Reference27 articles.
1. Kaufmann M. Zoladex in treatment of premenopausal metastatic breast cancer patients. Horm. Res. 1989, 32(Suppl. 1): 202–205.
2. Klijn J.G.M., De Jong F.H., Lamberts S.W.J., Blankenstein M.A. LHRH-agonist treatment in clinical and experimental human breast cancer. J. Steroid Biochem. 1985, 23: 867–873.
3. Nicholson R.I., Walker K.J., MeClelland R.A., Dixon A., Robertson R.I., Blamcy R.W. Zoladex plus tamoxifen versus Zoladex alone in pre and perimenopausal metastatic breast cancer. J. Steroid Biochem. Molec. Biol. 1990, 37: 989–995.
4. Fekete M., Zalatmai A., Comaru-Schally A.M., Schally A.V. Membrane receptors for peptides in experimental and human pancreatic cancers. Pancreas 1989, 4: 521–528.
5. Srkalovic G., Wittliff J.L., Schally A.V. Detection and partial characterization of receptors for (D-Trp6)-luteinizing-hormone releasing hormone and epidermal growth factor in human endometrial carcinoma. Cancer Res. 1990, 50: 1841–1846.
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献